IMMPORT THERAPEUTICS INC has a total of 25 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CELCUITY LLC, CEMM - FORSCHUNGSZENTRUM FÜR MOLEKULARE MEDIZIN GMBH and CELCUITY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | China | 3 | |
#5 | Mexico | 2 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Felgner Philip | 18 |
#2 | Liang Xiaowu | 18 |
#3 | Davies David Huw | 13 |
#4 | Molina Douglas | 4 |
#5 | Gennaro Maria Laura | 4 |
#6 | Philip Felgner | 3 |
#7 | Maria Laura Gennaro | 2 |
#8 | Randall Arlo | 2 |
#9 | Hermanson Gary | 2 |
#10 | Morrow William | 2 |
Publication | Filing date | Title |
---|---|---|
WO2017100598A1 | Babesia biomarkers for diagnostic and screening in vitro diagnostic test | |
CN104080477A | Methods and compositions of protein antigens for the diagnosis and treatment of herpes simplex viruses type 1 and 2 | |
CN103517714A | Methods and compositions of protein antigens for the diagnosis and treatment of toxoplasma gondii infections and toxoplasmosis | |
WO2012031122A2 | Methods and compositions for the diagnosis and treatment of cancer and autoimmune disorders | |
EP2429575A1 | Compositions and methods for immunodominant antigens of mycobacterium tuberculosis | |
WO2008140478A2 | Compositions and methods for immunodominant antigens |